Leyman Barbara (CIK 2028309) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-26). Recent activity: Buy STRO (25,000 shares), Sell STRO (8,944 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-26 | SUTRO BIOPHARMA, INC. (STRO) | Chief Business Officer | Buy | 25,000 | $0 |
| 2025-08-26 | SUTRO BIOPHARMA, INC. (STRO) | Chief Business Officer | Sell | 8,944 | $6,976 |
Source: SEC Form 4 filings · as of 2025-08-26